Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q4 2020 Results - Earnings Call Transcript

KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q4 2020 Results - Earnings Call Transcript

Kala Pharmaceuticals Inc.
Start Time: 08:00 End Time: 08:48 Kala Pharmaceuticals, Inc. (KALA) Q4 2020 Earnings Conference Call February 25, 2021, 08:00 AM ET Company Participants Mark Iwicki - Chairman, President and CEO Mary Reumuth - CFO Todd Bazemore - COO Kim Brazzell - Chief Medical Officer Hongming Chen - Chief Scientific Officer Niranjan Kameswaran - SVP, Strategy Conference Call Participants Christopher Neyor - JPMorgan Andreas Argyrides - Wedbush Securities François Brisebois - Oppenheimer Biren Amin - Jefferies Yi Chen - H.C. Wainwright Presentation Operator Good morning, and welcome to the Kala Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, a Q&A session will be held. As a reminder, this call is being recorded. I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed.

For further details see:

Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2020 Results - Earnings Call Transcript
Stock Information
Company Name: Kala Pharmaceuticals Inc.
Stock Symbol: KALA
Market: NASDAQ
Website: kalarx.com
Menu
KALA KALA Quote KALA Short KALA News KALA Articles KALA Message Board
Get KALA Alerts

News, Short Squeeze, Breakout and More Instantly...